Navigation Links
Reforming FDA: Focus on safety, let market judge efficacy

Editor's note: This is part II of a two-part column on the Food and Drug Administration approval process. Part I focused on the recent controversy over Avandia, GlaxoSmithKline's diabetes drug.

The primacy of efficacy over safety seems to be so deeply integral to the system that it migh......

Full article >>> terms of money and time) to generate the substantial evidence of drug efficacy.

Drug development now takes much longer. And in shifting priority from safety to efficacy, the Kefauver-Harris amendment has had the unintended consequence of slowing down drug approvals in the present era.

FDA: Tortoise or hare?

The

Source:wistechnology.com By Ogan Gurel 06/25/07


Related biology technology :

1. Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing
2. Sound Focus plans to enter home-entertainment market after taking Governors prize
3. DEMO 2003 Closes with Focus on Collaboration and Communication
4. Internet-enabled niche markets take center stage
5. GE Healthcare leads compact ultrasound market
6. Tech upstart VoVision could disrupt the voice-recognition market
7. Corn prices and ethanol: Are the markets flaky - or working as they should?
8. TomoTherapy sees sustained market advantage
9. Can a talent market work inside organizations?
10. Risks and returns: Building a search engine marketing portfolio
11. NimbleGen extends research market reach
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Aditya Humad, Acting CFO of AxioMed and Managing ... the United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying ... Humad went on to say that, “We expect interest to continue to rise as ...
(Date:12/9/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... to announce that Biohaven has issued today the following ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical ... that the U.S. Food and Drug Administration ("FDA") has ... drug candidate BHV-0223, an orally dissolving tablet being developed ...
(Date:12/8/2016)... ... , ... Lajollacooks4u, San Diego’s premier team building events and cooking events company, ... offerings and company expansion. , This is largely due to its team ... 30 people. Ever since, Lajollacooks4u has seen significant demand for its services from organizations ...
(Date:12/8/2016)... 8, 2016  Biotheranostics today announced that new ... the Breast Cancer Index (BCI) in identifying which ... most at-risk for disease recurrence and might benefit ... three studies advancing the understanding of the value ... biology and inform decisions related to patient treatment. ...
Breaking Biology Technology:
(Date:12/6/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, and the ... five (5) year funding commitment by Securus to ... rehabilitation and reentry support to more inmates and ... 2004, the Prison Entrepreneurship Program (PEP) is an ...
(Date:11/30/2016)... WARSAW, Poland , Nov. 30, 2016 Not many of us ... most crucial aspects of recovery so we need to do it well. Inadequate sleep ... heart problems, high blood pressure, stroke, diabetes, and even cancer. Maybe now ... a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... 29, 2016 Nearly one billion matches per second ... ... DERMALOG is Germany's ... efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification ...
Breaking Biology News(10 mins):